Full-Time

User Experience Researcher

Posted on 5/15/2025

IDEXX

IDEXX

5,001-10,000 employees

Diagnostic products for pet health

Compensation Overview

$100k - $120k/yr

+ Annual Cash Bonus

Mid, Senior

Company Does Not Provide H1B Sponsorship

Remote in USA + 1 more

More locations: Portland, ME, USA

This role is preferred to be hybrid out of the Westbrook ME office, but remote work is also considered for the right candidate.

Category
Product & UX/UI Design
UI/UX & Design
Required Skills
Data Analysis
Requirements
  • 4+ years Experience in UX research methodologies (e.g., Conjoint, MaxDiff, Qualitative Discovery, Usability)
  • Ability to effectively implement new tools and systems
  • Excellent organizational skills and strong attention to detail - project management experience a plus
  • Ability to effectively work on multiple projects simultaneously
  • Experience in working across functions
  • Ability to influence without authority
  • Proven experience in solving complex problems
Responsibilities
  • Collaborate with cross-functional partners across various domains (e.g., product management, marketing, data analysts, designers)
  • Implement growth hacking strategies (e.g., A/B testing, content marketing, community building) across the organization
  • Plan, design, execute, and analyze experiments to test growth hypotheses in consumer initiatives
  • Guide user personas and segmentation evolution based on data-backed insights
  • Present research findings and growth insights to stakeholders and leadership with actionable recommendations
  • Evaluate and implement systems and tools to track user behavior, measure performance, and make informed decisions about where to focus growth efforts
  • Consult on marketing strategies including content and design based on UX insights
  • Measure and modify campaign performance and optimization
  • Stay up-to-date with industry trends and best practices in growth hacking, digital marketing, and UX methodologies

IDEXX focuses on improving the health and well-being of pets, people, and livestock through a variety of diagnostic and information technology products and services. Their main offerings include in-clinic diagnostic tests, laboratory services, telemedicine consultations, and practice management software, all designed to help veterinarians provide better medical care and improve the efficiency of their practices. IDEXX also produces diagnostic tests for the livestock industry and ensures the safety of drinking water and milk. What sets IDEXX apart from its competitors is its extensive global reach, serving customers in over 175 countries and operating more than 70 locations worldwide. The company's goal is to raise the standard of care in veterinary medicine and enhance the health of animals and people globally.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Westbrook, Maine

Founded

1983

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising pet ownership boosts demand for IDEXX's diagnostic products.
  • Global veterinary diagnostics market expansion offers growth opportunities for IDEXX.
  • IDEXX's focus on sustainability aligns with industry trends and corporate responsibility goals.

What critics are saying

  • Increased competition from Zoetis and Heska may impact IDEXX's market share.
  • Rapid technological advancements require significant R&D investment, affecting profit margins.
  • Economic instability in Europe and Asia could reduce spending on veterinary services.

What makes IDEXX unique

  • IDEXX's Catalyst Platform offers real-time cortisol testing for canine endocrine disorders.
  • Procyte One analyzer uses advanced flow cytometry laser technology for precise diagnostics.
  • IDEXX's SpringBoard program provides free educational resources for veterinary residents.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Mental Health Support

Pet Insurance

Employee Stock Purchase Plan

Volunteer Paid Days Off

Company News

PR Newswire
Jun 5th, 2025
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

WESTBROOK, Maine, June 5, 2025 /PRNewswire/ - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst(R) Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs.

Daily Guardian
Feb 17th, 2025
South Korea Flow Cytometry Industry Trends, Key Players & Future Outlook: Rising Healthcare & Biotech Investments Drive South Korea Flow Cytometry Market Growth

February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology.

ETF Daily News
Dec 4th, 2024
Quantbot Technologies LP Makes New $341,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Quantbot Technologies LP makes new $341,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

Veterinary Practice News
Nov 12th, 2024
Industry partnership offers ACVIM residents free educational resources

The American College of Veterinary Internal Medicine (ACVIM) has partnered with IDEXX Laboratories, Inc. to endorse the SpringBoard program, offering complimentary, resident-focused educational resources.

MarketBeat
Oct 25th, 2024
Legacy Capital Group California Inc. Makes New $750,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Legacy Capital Group California Inc. makes new $750,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

INACTIVE